Price target upside
Vera Therapeutics, Inc. - Class A Common Stock Price Target Upside or Downside
VERA price target upside based on the current price and analyst average.
Direct answer
Vera Therapeutics, Inc. - Class A Common Stock's analyst target implies +172.9%.
The average target is $81.86 compared with a recorded current price of $29.99.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 12, 2026.
Get free Vera Therapeutics, Inc. - Class A Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $29.99
- Average price target
- $81.86
- High price target
- $125.00
- Low price target
- $43.00
- Target upside
- +172.9%
- Consensus rating
- Strong Buy
- Analysts
- 14
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026